VKTX
Viking Therapeutics, Inc.
$63.42
Earnings Summary
Revenue | $0Mn |
Net Profits | $-24.61Mn |
Net Profit Margins | -Inf% |
Highlights
Viking Therapeutics, Inc.’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Viking Therapeutics, Inc. has generated NaN% jump in its revenue since last 3-months.
Viking Therapeutics, Inc.’s net profit fell -30.63% since last year same period to $-24.61Mn in the Q4 2023. On a quarterly growth basis, Viking Therapeutics, Inc. has generated -9.19% fall in its net profits since last 3-months.
Viking Therapeutics, Inc.’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Viking Therapeutics, Inc. has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Viking Therapeutics, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.28 |
EPS Estimate Current Year | -0.28 |
Highlights
Viking Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.28 - a -12% fall from last quarter’s estimates.
Viking Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.28.
Key Ratios
Key ratios of the Viking Therapeutics, Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | -0.25 |
Highlights
Viking Therapeutics, Inc.’s earning per share (EPS) jumped 3.85% since last year same period to -0.25 in the Q4 2023. This indicates that the Viking Therapeutics, Inc. has generated 3.85% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-10-25 | -0.22 | -0.23 | -4.55% |
2024-02-07 | -0.25 | -0.25 | 0% |
2023-07-26 | -0.19 | -0.19 | 0% |
2023-04-26 | -0.24 | -0.25 | -4.17% |
₹0 US Stocks a/c Opening Fee